← Eichor
Study identifier: NCT05252754 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

Condition: Post-ERCP Acute Pancreatitis  ·  Sponsor: Johns Hopkins University

PhasePhase 3
Planned participants4874
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This research is being done to see if using oral tacrolimus before endoscopy, can prevent pancreatitis that may occur after ERCP (a type of gastrointestinal endoscopy).

This description comes directly from the study's public registry record.

Talk to the study team

Venkata S. Akshintala, M.D.  ·  +1 (410) 614-6708  ·  vakshin1@jhmi.edu

Always discuss trial participation with your own doctor first.

Locations (5)

Johns Hopkins HospitalBaltimore, Maryland, United StatesRecruiting
Asian Institute of GastroenterologyHyderabad, Andhra Pradesh, IndiaRecruiting
Apollo Multispecialty Hospitals,Kolkata, West Bengal, IndiaNot Yet Recruiting
Post Graduate Institute of Medical Education and ResearchChandigarh, IndiaNot Yet Recruiting
Singapore General HospitalSingapore, SingaporeNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05252754